LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about LEVICEPT LTD

Similar companies to LEVICEPT LTD

LEVICEPT LTD Tech Stack

LEVICEPT LTD uses 8 technology products and services including WordPress, MySQL, jQuery Migrate, and more. Explore LEVICEPT LTD's tech stack below.

  • WordPress
    Content Management System
  • MySQL
    Database
  • jQuery Migrate
    Javascript Libraries
  • Modernizr
    Javascript Libraries
  • Ubuntu
    Operating Systems
  • PHP
    Programming Languages
  • Apache
    Web Servers
  • ShareThis
    Widgets

LEVICEPT LTD's Email Address Formats

LEVICEPT LTD uses at least 1 format(s):
LEVICEPT LTD Email FormatsExamplePercentage
First@levicept.comJohn@levicept.com
50%
First@levicept.comJohn@levicept.com
50%

Frequently Asked Questions

Where is LEVICEPT LTD's headquarters located?

Minus sign iconPlus sign icon
LEVICEPT LTD's main headquarters is located at OFFICE 20, SECOND FLOOR INNOVATION HOUSE KENT, CT13 9FF GB. The company has employees across 2 continents, including EuropeNorth America.

What is LEVICEPT LTD's official website and social media links?

Minus sign iconPlus sign icon
LEVICEPT LTD's official website is levicept.com and has social profiles on LinkedIn.

How much revenue does LEVICEPT LTD generate?

Minus sign iconPlus sign icon
As of September 2024, LEVICEPT LTD's annual revenue reached $1.8M.

What is LEVICEPT LTD's SIC code NAICS code?

Minus sign iconPlus sign icon
LEVICEPT LTD's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does LEVICEPT LTD have currently?

Minus sign iconPlus sign icon
As of September 2024, LEVICEPT LTD has approximately 8 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: E. F.Chief Financial Officer: N. S.Vice President Clinical Operations: C. H.. Explore LEVICEPT LTD's employee directory with LeadIQ.

What industry does LEVICEPT LTD belong to?

Minus sign iconPlus sign icon
LEVICEPT LTD operates in the Biotechnology Research industry.

What technology does LEVICEPT LTD use?

Minus sign iconPlus sign icon
LEVICEPT LTD's tech stack includes WordPressMySQLjQuery MigrateModernizrUbuntuPHPApacheShareThis.

What is LEVICEPT LTD's email format?

Minus sign iconPlus sign icon
LEVICEPT LTD's email format typically follows the pattern of . Find more LEVICEPT LTD email formats with LeadIQ.

How much funding has LEVICEPT LTD raised to date?

Minus sign iconPlus sign icon
As of September 2024, LEVICEPT LTD has raised $3.9M in funding. The last funding round occurred on Oct 08, 2014 for $3.9M.

When was LEVICEPT LTD founded?

Minus sign iconPlus sign icon
LEVICEPT LTD was founded in 2012.
LEVICEPT LTD

LEVICEPT LTD

Biotechnology ResearchKENT, United Kingdom2-10 Employees

Levicept Ltd is a UK-based biotechnology company developing a novel, safe and efficacious biological therapy (LEVI-04 [p75NTR-Fc]) for the treatment of chronic pain. LEVI-04 is currently in a phase II study in patients with osteoarthritis of the knee.

Section iconCompany Overview

Headquarters
OFFICE 20, SECOND FLOOR INNOVATION HOUSE KENT, CT13 9FF GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
2-10

Section iconFunding & Financials

  • $3.9M

    LEVICEPT LTD has raised a total of $3.9M of funding over 2 rounds. Their latest funding round was raised on Oct 08, 2014 in the amount of $3.9M.

  • $10M

    LEVICEPT LTD's revenue is in the range of $10M

Section iconFunding & Financials

  • $3.9M

    LEVICEPT LTD has raised a total of $3.9M of funding over 2 rounds. Their latest funding round was raised on Oct 08, 2014 in the amount of $3.9M.

  • $10M

    LEVICEPT LTD's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.